Transgene Biotek Ltd

NSE: TRABI · BSE: 526139 · Healthcare · 14 announcements

Share price: ₹2.37
Market cap: ₹17.96 Cr
Revenue (annual): ₹0.21 Cr
Net profit (annual): ₹-1.65 Cr
P/E (TTM): -11.2×Sector 53.1×
Promoter holding: 23.64%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Management Change 2 Fund Raise 1 Debt & Borrowing 1 Capital Structure Change 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

23 Sep 2026 19:46 IST BSE

Management Change

Transgene Biotek Management Change

Transgene Biotek Ltd announced the resignation of M/s Vasavi & Co. as Statutory Auditors, effective immediately. The auditors cited pre-occupation with other assignments as the reason.

Read the filing ↗

7 Aug 2026 11:57 IST BSE

Management Change

Transgene Biotek Management Change

Transgene Biotek Limited has appointed M/s Manisha Dubey & Associates as Internal Auditors for a 12-month term. The board approved the appointment during its August 7, 2026 meeting.

Execution: 12 months

Read the filing ↗